Amyloid Antibodies and the Role of the Geriatrician: Nate Chin, Sharon Brangman, and Jason Karlawish
GeriPal
AUGUST 17, 2023
The outlook on amyloid antibodies are looking brighter though in 2023. And we’ve been diagnosing it at Penn. I think the other issue as geriatricians and we need to educate our patients about is now you’re not on one, but six months later on this drug, you go on one. Before you go on it. What do you think, Nate?
Let's personalize your content